This study is aimed at observing the therapeutic effect of κ-OR agonist U50488H on cardiac functions and ERS response in HF rats and to investigate the regulatory mechanisms of the Nrf2/HO-1 signaling pathway to provide theoretical basis for the clinical drug development in HF. This evidence concerns the gene OPRK1 and hydrops fetalis.